Abstract
Multiple studies suggest an association between cytomegalovirus (CMV) infection and atherogenesis; however, the molecular mechanisms by which viral infection might exacerbate atherosclerosis are not well understood. Aortas of MCMV-infected and uninfected Apo E knockout (KO) mice were analyzed for atherosclerotic lesion development and differential gene expression. Lesions in the infected mice were larger and showed more advanced disease compared to the uninfected mice. Sixty percent of the genes in the MAPK pathway were upregulated in the infected mice. p38 and ERK 1/2 MAPK genes were 5.6- and 2.0-fold higher, respectively, in aortas of infected vs. uninfected mice. Levels of VCAM-1, ICAM-1, and MCP-1 were ~2.0–2.6-fold higher in aortas of infected vs. uninfected mice. Inhibition of p38 with SB203580 resulted in lower levels of pro-atherogenic molecules and MCMV viral load in aortas of infected mice. MCMV-induced upregulation of p38 may drive the virus-induced acceleration of atherogenesis observed in our model.
Similar content being viewed by others
References
Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362, 801–809.
Glass, C. K., & Witztum, J. L. (2001). Atherosclerosis. The road ahead. Cell, 104, 503–516.
Hansson, G. K., & Libby, P. (2006). The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology, 6, 508–519.
Orange, J. S., & Biron, C. A. (1996). Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. Journal of Immunology, 156, 4746–4756.
Tang-Feldman, Y. J., Wojtowicz, A., Lochhead, G. R., Hale, M. A., Li, Y., & Pomeroy, C. (2006). Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection. Journal of Virological Methods, 131, 122–129.
Ritter, J. T., Tang-Feldman, Y. J., Lochhead, G. R., Estrada, M., Lochhead, S., Yu, C., et al. (2010). In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis. Cardiovascular Pathology, 19, 83–93.
Blum, A., Giladi, M., Weinberg, M., Kaplan, G., Pasternack, H., Laniado, S., et al. (1998). High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. The American Journal of Cardiology, 81, 866–868.
Grattan, M. T., Moreno-Cabral, C. E., Starnes, V. A., Oyer, P. E., Stinson, E. B., & Shumway, N. E. (1989). Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. Journal of the American Medical Association, 261, 3561–3566.
Espinola-Klein, C., Rupprecht, H. J., Blankenberg, S., Bickel, C., Kopp, H., Victor, A., et al. (2002). Impact of infectious burden on progression of carotid atherosclerosis. Stroke, 33, 2581–2586.
Hendrix, M. G., Dormans, P. H., Kitslaar, P., Bosman, F., & Bruggeman, C. A. (1989). The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. American Journal of Pathology, 134, 1151–1157.
Zhou, Y. F., Guetta, E., Yu, Z. X., Finkel, T., & Epstein, S. E. (1996). Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. The Journal of Clinical Investigation, 98, 2129–2138.
Hsich, E., Zhou, Y. F., Paigen, B., Johnson, T. M., Burnett, M. S., & Epstein, S. E. (2001). Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. Atherosclerosis, 156, 23–28.
Rodems, S. M., & Spector, D. H. (1998). Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. Journal of Virology, 72, 9173–9180.
Johnson, R. A., Ma, X. L., Yurochko, A. D., & Huang, E. S. (2001). The role of MKK1/2 kinase activity in human cytomegalovirus infection. Journal of General Virology, 82, 493–497.
Johnson, R. A., Huong, S. M., & Huang, E. S. (2000). Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. Journal of Virology, 74, 1158–1167.
Hu, Y., Cheng, L., Hochleitner, B. W., & Xu, Q. (1997). Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 2808–2816.
Fledderus, J. O., van Thienen, J. V., Boon, R. A., Dekker, R. J., Rohlena, J., Volger, O. L., et al. (2007). Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2. Blood, 109, 4249–4257.
Pomeroy, C., Hilleren, P. J., & Jordan, M. C. (1991). Latent murine cytomegalovirus DNA in splenic stromal cells of mice. Journal of Virology, 65, 3330–3334.
Henry, S. C., Schmader, K., Brown, T. T., Miller, S. E., Howell, D. N., Daley, G. G., et al. (2000). Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. Journal of Virological Methods, 89, 61–73.
Heise, M. T., & Virgin, H. W. (1995). The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. Journal of Virology, 69, 904–909.
Kipar, A., Leutenegger, C. M., Hetzel, U., Akens, M. K., Mislin, C. N., Reinacher, M., et al. (2001). Cytokine mRNA levels in isolated feline monocytes. Veterinary Immunology and Immunopathology, 78, 305–315.
da Huang, W., Sherman, B. T., & Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4, 44–57.
da Huang, W., Sherman, B. T., & Lempicki, R. A. (2009). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research, 37, 1–13.
Mayr, M., Kiechl, S., Willeit, J., Wick, G., & Xu, Q. (2000). Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation, 102, 833–839.
Leskov, I. L., Whitsett, J., Vasquez-Vivar, J., & Stokes, K. Y. (2011). NAD(P)H oxidase and eNOS play differential roles in cytomegalovirus infection-induced microvascular dysfunction. Free Radical Biology & Medicine, 51, 2300–2308.
Burnett, M. S., Durrani, S., Stabile, E., Saji, M., Lee, C. W., Kinnaird, T. D., et al. (2004). Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes. Circulation, 109, 893–897.
Vliegen, I., Stassen, F., Grauls, G., Blok, R., & Bruggeman, C. (2002). MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice. Journal of Clinical Virology, 25(Suppl 2), S159–S171.
Vliegen, I., Duijvestijn, A., Stassen, F., & Bruggeman, C. (2004). Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis. Microbes and Infection, 6, 1056–1062.
Vliegen, I., Herngreen, S. B., Grauls, G. E., Bruggeman, C. A., & Stassen, F. R. (2005). Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice. Atherosclerosis, 181, 39–44.
Stassen, F. R., Vega-Cordova, X., Vliegen, I., & Bruggeman, C. A. (2006). Immune activation following cytomegalovirus infection: more important than direct viral effects in cardiovascular disease? Journal of Clinical Virology, 35, 349–353.
Chen, Y., & Currie, R. W. (2005). Heat shock treatment suppresses angiotensin II-induced SP-1 and AP-1 and stimulates Oct-1 DNA-binding activity in heart. Inflammation Research, 54, 338–343.
Goebeler, M., Kilian, K., Gillitzer, R., Kunz, M., Yoshimura, T., Brocker, E. B., et al. (1999). The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood, 93, 857–865.
Marin, V., Farnarier, C., Gres, S., Kaplanski, S., Su, M. S., Dinarello, C. A., et al. (2001). The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment. Blood, 98, 667–673.
Domoto, K., Taniguchi, T., Takaishi, H., Takahashi, T., Fujioka, Y., Takahashi, A., et al. (2003). Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells. Atherosclerosis, 171, 193–200.
Mei, S., Gu, H., Ward, A., Yang, X., Guo, H., He, K., et al. (2012). p38 mitogen-activated protein kinase (MAPK) promotes cholesterol ester accumulation in macrophages through inhibition of macroautophagy. Journal of Biological Chemistry, 287, 11761–11768.
Hall-Jackson, C. A., Goedert, M., Hedge, P., & Cohen, P. (1999). Effect of SB 203580 on the activity of c-Raf in vitro and in vivo. Oncogene, 18, 2047–2054.
Badger, A. M., Bradbeer, J. N., Votta, B., Lee, J. C., Adams, J. L., & Griswold, D. E. (1996). Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. Journal of Pharmacology and Experimental Therapeutics, 279, 1453–1461.
Hollenbach, E., Neumann, M., Vieth, M., Roessner, A., Malfertheiner, P., & Naumann, M. (2004). Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. The FASEB Journal, 18, 1550–1552.
Renda, T., Baraldo, S., Pelaia, G., Bazzan, E., Turato, G., Papi, A., et al. (2008). Increased activation of p38 MAPK in COPD. European Respiratory Journal, 31, 62–69.
Matsumoto, T., Yokote, K., Tamura, K., Takemoto, M., Ueno, H., Saito, Y., et al. (1999). Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration. Journal of Biological Chemistry, 274, 13954–13960.
Acknowledgments
The authors thank the Lucy Whittier Molecular Core Facility at the School of Veterinary Medicine, UC Davis, for excellent technical assistance with the RNA extraction and cDNA synthesis. We are grateful to Mr. Matthew Rolston at the UC Davis School of Medicine DNA Microarray Core Facility for assistance with the DNA microarray analyses.
This work was supported in part by an Innovative Development Award (YTF) from UC Davis Academic Federation and by grant UL1 RRO24146 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Road Map for Medical Research (CP), and the Frances Lazda Endowment in Women’s Cardiovascular Medicine (ACV).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Figure 1
Canonical signaling pathways upregulated in Apo E Knockout mice compared to wild-type, C57BL/6. Figure is generated by the Ingenuity Pathway Analysis Software. (JPEG 143 kb)
Supplementary Figure 2
Effect of p38 inhibitor, SB203580, on c-Raf/MEK/ERK1/2 pathway. a mRNA levels of c-Raf in aortas of MCMV-infected, SB203580 treated and untreated Apo E KO mice; b mRNA levels of Map2K1 in aortas of MCMV-infected, SB203580 treated and untreated Apo E KO mice; c mRNA levels of ERK1/2 in aortas of MCMV-infected, SB203580 treated and untreated Apo E KO mice. (n = 5 mice treated vs. untreated). Mice were treated as described in “Materials and Methods”. (JPEG 25 kb)
Rights and permissions
About this article
Cite this article
Tang-Feldman, Y.J., Lochhead, S.R., Lochhead, G.R. et al. Murine Cytomegalovirus (MCMV) Infection Upregulates P38 MAP kinase in Aortas of Apo E KO Mice: a Molecular Mechanism for MCMV-Induced Acceleration of Atherosclerosis. J. of Cardiovasc. Trans. Res. 6, 54–64 (2013). https://doi.org/10.1007/s12265-012-9428-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-012-9428-x